A Study to Assess the Effect of Tocilizumab + DMARD Therapy on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis

Hong Kong

Tuenmen

Radiokop

Sydney

Parkville

Durban

Saint-Etienne

New York

San José

Bangkok

Bangkok

Roslyn

Smithtown

Plainview

Syracuse

Marseille

Mexico City

Pittsburgh

Santiago de Compostela

Bethlehem

Allentown

Rockledge

Willow Grove

Philadelphia

Newark

Washington D.C.

Frederick

Arlington

Tijuana

Winston-Salem

Raleigh

Durham

Madrid

Madrid

Málaga

Charleston

Hildesheim

Panama City

Jupiter

Delray Beach

Tampa

Montpellier

Palm Habor

Palm Harbor

Rennes

Pontevedra

León

Tours

Nashville

Hixson

Grenoble

Jyväskylä

Bowling Green

Nantes

Beachwood

Cincinnati

Essen

Dayton

Gallipolis

Indianapolis

Sendenhorst

Barakaldo

Lansing

Osnabrück

Chiang Mai

Aachen

Milwaukee

La Crosse

Eagan

Saint Louis Park

Duluth

Vernon Hills

Chicago

Chicago

Springfield

Clermont-Ferrand

St Louis

Springfield

Lincoln

Pierre-Bénite

Stuttgart

Baton Rouge

Shreverport

Little Rock

Oklahoma City

Oklahoma City

Tulsa

Mesquite

Paris

Houston

Austin

München

Mesa

Paradise Valley

Scottsdale

Peoria

Tucson

Limoges

Albuquerque

Reno

Los Angeles

Umeå

Upland

Boulogne-Billancourt

Palm Desert

Palo Alto

San Jose

Medford

Tacoma

Vancouver

Spokane

Beijing

Beijing

Moscow

Moscow

Moscow

Saint Petersburg

Saint Petersburg

Shanghai

Shanghai

Tula

Ryazan

Boston

Clifton

Haddon Heights

New Brunswick

Johnston

Burlington

Buenos Aires

Buenos Aires

Rosario

Campinas

Goiânia

Rio de Janeiro

Winnipeg

Hamilton

Ottawa

Québec

Saskatoon

Hradec Králové

Prague

Prague

Helsinki

Mexico City

Pretoria

Stockholm